FDA Office Of Drug Evaluation III Approves Salix Pharmaceuticals, Ltd. 's Request That The FDA Approve The RELISTOR Subcutaneous Injection sNDA For The Treatment Of Opioid-Induced Constipation In Patients With Chronic Non-Cancer Pain RALEIGH, N.C. & TARRYTOWN, N.Y.-- --Salix Pharmaceuticals, Ltd. and Progenics Pharmaceuticals today announced that ... (more)
http://ift.tt/1yi7Ipv
http://ift.tt/1yi7Ipv
No comments:
Post a Comment